Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Interpretation of random effects meta-analysesBMJ, 2011-02, Vol.342 (7804), p.964-967 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2011 ;Copyright: 2011 © BMJ Publishing Group Ltd 2011 ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d549 ;PMID: 21310794Full text available |
|
2 |
Material Type: Article
|
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trialsBMJ, 2011-07, Vol.343 (7818), p.302-307 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2011 ;Copyright: 2011 © BMJ Publishing Group Ltd 2011 ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d4002 ;PMID: 21784880Full text available |
|
3 |
Material Type: Article
|
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ (Online), 2021-03, Vol.372, p.n71-n71 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n71 ;PMID: 33782057Full text available |
|
4 |
Material Type: Article
|
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guidelineBMJ (Online), 2020-01, Vol.368, p.l6890-l6890 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6890 ;PMID: 31948937Full text available |
|
5 |
Material Type: Article
|
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviewsBMJ (Online), 2021-03, Vol.372, p.n160-n160 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n160 ;PMID: 33781993Full text available |
|
6 |
Material Type: Article
|
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ, 2009-07, Vol.339 (7716), p.332-336 [Peer Reviewed Journal]Moher et al 2009 ;2009 BMJ Publishing Group Ltd ;Copyright BMJ Publishing Group LTD Jul 21, 2009 ;Moher et al 2009 2009 Moher et al ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.b2535 ;PMID: 19622551Full text available |
|
7 |
Material Type: Article
|
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothBMJ (Online), 2017-09, Vol.358, p.j4008-j4008 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j4008 ;PMID: 28935701Full text available |
|
8 |
Material Type: Article
|
Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklistBMJ (Online), 2020-08, Vol.370, p.m2632-m2632 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2632 ;PMID: 32816740Full text available |
|
9 |
Material Type: Article
|
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database surveyBMJ, 2012-01, Vol.344 (7838), p.16-16 [Peer Reviewed Journal]Ahmed et al 2011 ;Copyright: 2011 © Ahmed et al 2011 ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d7762 ;PMID: 22214758Full text available |
|
10 |
Material Type: Article
|
A guide to systematic review and meta-analysis of prognostic factor studiesBMJ (Online), 2019-01, Vol.364, p.k4597-k4597 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2019BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4597 ;PMID: 30700442Full text available |
|
11 |
Material Type: Article
|
Meta-analysis of individual participant data: rationale, conduct, and reportingBMJ, 2010-02, Vol.340 (7745), p.521-525 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2010 ;2010 BMJ Publishing Group Ltd ;Copyright BMJ Publishing Group LTD Feb 5, 2010 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.c221 ;PMID: 20139215Full text available |
|
12 |
Material Type: Article
|
Overlapping meta-analyses on the same topic: survey of published studiesBMJ (Online), 2013-07, Vol.347 (7921), p.12-12 [Peer Reviewed Journal]Siontis et al 2013 ;BMJ Publishing Group Ltd 2013 ;Copyright: 2013 © Siontis et al 2013 ;Siontis et al 2013 2013 Siontis et al ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.f4501 ;PMID: 23873947Full text available |
|
13 |
Material Type: Article
|
Uncertainty in heterogeneity estimates in meta-analysesBMJ, 2007-11, Vol.335 (7626), p.914-916 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2007 ;Copyright 2007 BMJ Publishing Group Ltd. ;Copyright: 2007 (c) BMJ Publishing Group Ltd 2007 ;BMJ Publishing Group Ltd 2007 2007 BMJ Publishing Group Ltd ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.39343.408449.80 ;PMID: 17974687Full text available |
|
14 |
Material Type: Article
|
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008-03, Vol.336 (7644), p.601-605 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2008 ;Copyright 2008 BMJ Publishing Group Ltd. ;Copyright: 2008 (c) BMJ Publishing Group Ltd 2008 ;BMJ Publishing Group Ltd 2008 2008 BMJ Publishing Group Ltd ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.39465.451748.AD ;PMID: 18316340Full text available |
|
15 |
Material Type: Article
|
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challengesBMJ (Online), 2016-06, Vol.353, p.i3140-i3140 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD Jun 22, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2016 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i3140 ;PMID: 27334381Full text available |
|
16 |
Material Type: Article
|
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsBMJ (Online), 2021-01, Vol.372, p.m4573 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m4573 ;PMID: 33441402Full text available |
|
17 |
Material Type: Article
|
Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trialsBMJ (Online), 2020-04, Vol.369, p.m696-m696 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m696 ;PMID: 32238384Full text available |
|
18 |
Material Type: Article
|
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analysesBMJ, 2012-01, Vol.344 (7838), p.13-13 [Peer Reviewed Journal]Hart et al 2011 ;Copyright: 2011 © Hart et al 2011 ;ISSN: 0959-8138 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.d7202 ;PMID: 22214754Full text available |
|
19 |
Material Type: Article
|
Drug treatments for covid-19: living systematic review and network meta-analysisBMJ, 2020-07, Vol.370, p.m2980 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2980 ;PMID: 32732190Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysisBMJ (Online), 2022-05, Vol.377, p.e069989-e069989 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-069989 ;PMID: 35640925Full text available |